ALNYLAM PHARMACEUTICALS INC (DUL.DE) Stock Analyst Ratings
Europe - Frankfurt Stock Exchange - FRA:DUL - US02043Q1076 - Common Stock
333.4 EUR
+12.4 (+3.86%)
ChartMill assigns a Buy % Consensus number of 79% to DUL.DE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 393.52. This target is 18.03% above the current price.
DUL.DE was analyzed by 37 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about DUL.DE.
In the previous month the buy percentage consensus was at a similar level.
DUL.DE was analyzed by 37 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-08-04 | Barclays | Maintains | Overweight |
| 2021-08-04 | Morgan Stanley | Maintains | Overweight |
| 2021-08-04 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2021-07-16 | Morgan Stanley | Maintains | Overweight |
| 2021-04-30 | Morgan Stanley | Maintains | Overweight |
| 2021-02-22 | Guggenheim | Downgrade | Buy -> Neutral |
| 2021-02-12 | Needham | Maintains | Buy |
| 2021-02-12 | Barclays | Maintains | Overweight |
| 2021-02-12 | Morgan Stanley | Maintains | Overweight |
| 2021-02-12 | Citigroup | Downgrade | Buy -> Neutral |
| 2021-02-12 | HC Wainwright & Co. | Maintains | Buy |
ALNYLAM PHARMACEUTICALS INC / DUL.DE FAQ
Can you provide the average price target for ALNYLAM PHARMACEUTICALS INC stock?
37 analysts have analysed DUL.DE and the average price target is 393.52 EUR. This implies a price increase of 18.03% is expected in the next year compared to the current price of 333.4.
How do analysts rate ALNYLAM PHARMACEUTICALS INC (DUL.DE)?
The consensus rating for ALNYLAM PHARMACEUTICALS INC (DUL.DE) is 78.9189 / 100 . This indicates that analysts generally have a positive outlook on the stock.